Recent developments in human papillomavirus vaccines.

about

Translational mini-review series on vaccines: Monitoring of human papillomavirus vaccination.Monitoring of human papillomavirus vaccination.

P2860

Q36793117-1903B29B-F51C-497A-A224-CF933AD3858A Q37808256-20182A9B-D289-4C5E-A89F-892331E61D08

P2860

Recent developments in human papillomavirus vaccines.

Item

http://www.wikidata.org/entity/Q35842528

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Recent developments in human papillomavirus vaccines.

@ast

Recent developments in human papillomavirus vaccines.

@en

type

Item

label

Recent developments in human papillomavirus vaccines.

@ast

Recent developments in human papillomavirus vaccines.

@en

prefLabel

Recent developments in human papillomavirus vaccines.

@ast

Recent developments in human papillomavirus vaccines.

@en

P1476

Recent developments in human papillomavirus vaccines.

@en

P2093

Peter L Stern

http://www.w3.org/2001/XMLSchema#string

P2860

The causal relation between human papillomavirus and cervical cancer.

The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.

The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.

Papillomavirus-like particle vaccines for cervical cancer.

Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site

Immunization with a pentameric L1 fusion protein protects against papillomavirus infection.

Cost-effectiveness of a potential vaccine for human papillomavirus.

The prime-boost strategy: exciting prospects for improved vaccination.

Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles.

P304

959-971

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.13.8.959

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15268634

http://www.w3.org/2001/XMLSchema#string

Recent developments in human papillomavirus vaccines.

about

P2860

P2860

Recent developments in human papillomavirus vaccines.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698